Andrew H Karaba Selected Research

Interferons

1/2022

Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew H Karaba Research Topics

Disease

16	COVID-19 04/2024 - 01/2021
10	Infections 01/2023 - 10/2011
5	Breakthrough Infections 01/2022 - 10/2021
2	COVID-19 related pediatric multisystem inflammatory disease 01/2024 - 11/2023
2	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 12/2014
1	Critical Illness (Critically Ill) 01/2024
1	Lymphopenia (Lymphocytopenia) 01/2024
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Human Influenza (Influenza) 01/2022
1	Frailty 01/2022
1	Melanoma (Melanoma, Malignant) 01/2020
1	Herpetic Keratitis 10/2015
1	Eye Infections 01/2013
1	Herpes Simplex 06/2012
1	Neuroblastoma 06/2012

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 04/2024 - 10/2021
4	Messenger RNA (mRNA)IBA 04/2024 - 01/2022
4	ChemokinesIBA 01/2024 - 01/2021
4	Cell-Free Nucleic AcidsIBA 01/2024 - 01/2022
4	CytokinesIBA 01/2024 - 01/2021
3	mRNA VaccinesIBA 04/2024 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2021
3	Interleukin-18 (Interleukin 18)IBA 01/2022 - 01/2020
3	NectinsIBA 12/2014 - 10/2011
2	Immunoglobulin G (IgG)IBA 04/2024 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2022
2	cilgavimabIBA 01/2023 - 01/2023
2	AntibodiesIBA 01/2023 - 01/2022
2	tixagevimabIBA 01/2023 - 01/2023
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 01/2022
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2022
2	Interleukin-15 (Interleukin 15)IBA 01/2022 - 01/2022
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 01/2022
2	COVID-19 VaccinesIBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	Member 14 Tumor Necrosis Factor ReceptorsIBA 10/2015 - 10/2011
1	Combined VaccinesIBA 04/2024
1	Monoclonal AntibodiesIBA 01/2023
1	Ad26COVS1IBA 01/2023
1	AcidsIBA 12/2022
1	Coloring Agents (Dyes)IBA 12/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	InterferonsIBA 01/2022
1	Chemokine CCL8IBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	InflammasomesIBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Leucine (L-Leucine)FDA Link 01/2020
1	NucleotidesIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 12/2012
1	Antiviral Agents (Antivirals)IBA 06/2012
1	Acyclovir (Aciclovir)FDA LinkGeneric 06/2012

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 06/2012